Johnson & Johnson (JNJ) EPS (Diluted) (2009 - 2026)
Johnson & Johnson (JNJ) recorded EPS (Diluted) of $0.09 in Q3 2026, down 96.0% from $2.12 a year earlier and down 96.2% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a TTM basis, Johnson & Johnson's EPS (Diluted) came in at $6.57 as of Sep 27, 2026, down 36.4% year-over-year; for FY2025, it came in at $11.03, up 90.6% from FY2024.
- Annual EPS (Diluted) has a four-year compound annual growth rate of 19.0% (FY2021 to FY2025).
- Across earlier years, EPS (Diluted) came in at $5.79 in FY2024 (-57.8%), $13.73 in FY2023 (+103.9%), $6.73 in FY2022 and $5.51 in FY2021.
- The Q3 2026 figure is the lowest quarterly EPS (Diluted) since Q1 2023.
- On a year-over-year basis, EPS (Diluted) has declined for three consecutive quarters, with growth averaging 29.6% over the last eight quarters.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 238.8% in Q1 2025, against a decline of 96.0% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.27 (Q2 2026), $2.14 (Q1 2026) and $2.11 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -0.04 |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 4.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 0.09 |
| Jun 28, 2026 | 2.27 |
| Mar 29, 2026 | 2.14 |
| Dec 28, 2025 | 2.11 |
| Sep 28, 2025 | 2.12 |
| Jun 29, 2025 | 2.29 |
| Mar 30, 2025 | 4.54 |
| Dec 29, 2024 | 1.41 |
| Sep 29, 2024 | 1.11 |
| Jun 30, 2024 | 1.93 |
| Mar 31, 2024 | 1.34 |
| Dec 31, 2023 | 1.58 |
| Oct 1, 2023 | 10.21 |
| Jul 2, 2023 | 1.96 |
| Apr 2, 2023 | -0.03 |
| Jan 1, 2023 | 1.32 |
| Oct 2, 2022 | 1.68 |
| Jul 3, 2022 | 1.80 |
| Apr 3, 2022 | 1.93 |
| Oct 3, 2021 | 1.37 |
API Access
Johnson & Johnson EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();